Objective-The goal of this study was systematic profiling of vasodilator-stimulated phosphoprotein (VASP)-Ena/VASP homology 1 (EVH1) interactors in human platelets using a combined in silico and in vitro approach. Methods and Results-Exploiting the information of the comprehensive proteome catalogue in the PlateletWeb database (http://plateletweb.bioapps.biozentrum.uni-wuerzburg.de/PlateletWeb.php), we performed a motif search of all sequences and identified potential target sites of class I EVH1 domains in human platelet proteins. Performing affinity purification with VASP-EVH1 domain and the lysates of platelets, we examined complex partners by mass spectrometry. Combining the results of both analyses, we identified Abelson interactor 1 (Abi-1) as a novel EVH1 domain-specific interaction partner of VASP in human platelets and investigated this interaction by yeast 2-hybrid mutational studies and immunoprecipitation. Immunofluorescence microscopy indicated colocalization of both proteins at the lamellipodia of spread human platelets, suggesting a role in reorganizing the cytoskeleton during spreading. Conclusion-The combination of experimental and computational interactome research has emerged as a valuable tool for the analysis of protein-protein interaction networks and facilitates the discovery and characterization of novel interactions as detailed here for Abi-1 and VASP in human platelets. System biological approaches can be expected to play an important role in basic and clinical platelet research, as they offer the potential to analyze signal transduction beyond the scope of established pathways. (Arterioscler Thromb Vasc Biol. 2010;30:843-850.)
T he focus of biological research is currently shifting from the investigation of individual genes and proteins toward the analysis of entire biological systems. In connection with this, high-throughput analyses accumulate growing amounts of proteome, transcriptome, and interactome data. Particularly in the field of platelet research, a considerable number of mass spectrometric studies have set out to identify the complete repertoire of proteins expressed in human platelets. 1, 2 To make this wealth of information biologically exploitable, we recently established a platelet database integrating proteomic and interaction data sources and assembled a first model of the platelet proteome and interactome from these data. 3 The entire network can be browsed online.
Apart from their central physiological role in hemostasis, platelets are involved in inflammatory processes of the immune system and play a role in the pathophysiology of several cardiovascular diseases. Aggregation and spreading of platelets are accompanied by major changes in platelet morphology and in reorganization of the actin cytoskeleton, 4 up to the appearance of actin nodules. It has been proposed that these nodules play a major role in actin dynamics. 5 Defects in key proteins of the cytoskeleton organization, such as Wiskott-Aldrich syndrome protein, result in severe effects associated with impaired platelet function. 6 The importance of actin organization and intracellular signaling is further underlined by the results of a previous network analysis of the platelet interactome model: Proteins with a particularly high connectivity in platelets (platelet-specific "hubs") are often involved in the remodeling of the actin cytoskeleton. 3 One of the key regulators of the actin cytoskeleton in platelets is vasodilator-stimulated phosphoprotein (VASP), 7 which belongs to the Enabled/VASP (Ena/VASP) family. Members of this family influence many actin-dependent processes in cells: In vitro, they bind monomeric actin and profilin-actin, interfere with barbed end capping, and bundle filaments, all of which could promote actin assembly (reviewed by Chesarone and Goode 8 ). Moreover, it has recently been shown that VASP accelerates barbed-end elongation. 9 However, the detailed function of VASP in vivo is under intensive discussion (reviewed by Bear and Gertler 10 ), and the interacting partners in the different mechanisms of VASP function have not been completely defined yet.
A common trait of all Ena/VASP family proteins is the Ena/VASP homology 1 (EVH1) domain, located at the N terminus of the amino acid sequence. 11, 12 This domain mediates important protein-protein interactions that regulate the function of these proteins in the modulation and reorganization of the actin cytoskeleton. 11 In particular, class I EVH1 domains, such as the VASP EVH1 domain, characteristically interact with polyproline-rich regions (FP 4 motif), 12 although exceptions to this rule have recently been discovered. 13 To contribute to further understanding of Ena/VASP proteins in human platelets, we used a concerted in silico and in vitro approach to analyze EVH1 domain-specific interactions in platelets. First, we searched for class I EVH1 target sites in the entire set of proteins in our platelet database. 3 Using the VASP EVH1 domain as bait, we subsequently performed affinity purifications with lysates of purified human platelets to screen for potential interaction partners by mass spectrometry. Both analyses identified Abelson interactor 1 (Abi-1) as a novel EVH1 domain-specific interaction partner of VASP in human platelets. By means of extensive yeast 2-hybrid (Y2H) mutational studies of both interaction partners, we further characterized this interaction in detail. Finally, immunofluorescence microscopy revealed colocalization of both proteins at the lamellipodia of spread human platelets.
Methods
Expanded methods are described in the supplementary materials (available online at http://atvb.ahajournals.org). All experiments were performed using human platelets from healthy donors. This study was conducted in accordance with the Declaration of Helsinki and was approved by the local medical ethics committee (study number 114/04; 67/92). Highly purified platelets were prepared as described previously. 14 Glutathione S-transferase (GST) and GST-VASP (1 to 115) or GST-Abi-1 (1 to 388, full length) were expressed in Escherichia coli, and affinity chromatography was performed using lysate of highly purified platelets as described in the supplementary materials. Eluted proteins were analyzed by Coomassie blue staining and subsequent mass spectrometry or with Western blotting and specific antibodies.
Y2H analysis was performed according to the Clontech Matchmaker Two-Hybrid System 3 protocol. Clones expressing both the bait and the prey were selected on a growth medium lacking leucine and tryptophan, and the interacting proteins were identified for their adenine and histidine auxotroph complementation and their ␤-galactosidase expression, as described in further detail in the supplementary materials.
Bioinformatics was as follows: Protein sequences from the Plate-letWeb 3 were used as a database for the motif search. The positionspecific scoring matrix of the search motif was created on the basis of a curated alignment of established EVH1 target sites. 11
Results

Subnetwork Interactors of VASP and EVH1 Domains in Human Platelets
Data on the platelet proteome and transcriptome are accumulating at an unprecedented speed. To tap the full potential of this huge amount of data in the field of platelet proteins, we collected a large amount of published data and established a comprehensive platelet proteome and transcriptome database. 3 Integrating protein-protein interaction data derived from literature, public databases, and Y2H screens, we established a first model of the platelet-specific interactome. 3 Different domains of a protein and their domain-specific interactions are frequently involved in distinct cellular functions. Thus, a comprehensive understanding of the multifaceted functions of a protein often requires an interaction analysis on the level of individual domains.
Many EVH1 domain containing proteins play a crucial role in the cytoskeleton reorganization process during shape change of platelets on activation. To obtain a more detailed view of the role of EVH1 proteins in the intricate processes of actin polymerization in platelets, we first constructed a subnetwork of direct VASP interaction partners ( Figure 1A ) based on the PlateletWeb database (novel and extended version, May 2009). Because these interactions are not yet domain-specific, we find, besides EVH1 domain-specific interactors such as zyxin (ZYX), 16 vinculin (VCL), 17 and FYN-binding protein (FYB), 18 also spectrin (SPTA2) 19 and profilin (PFN) 20 which bind to the polyproline-rich region in the central part of VASP, ␣-actin, and ␥-actin (ACTA1/ACTG1) 21, 22 as interactors of the EVH2 domain, as well as phosphorylations by protein kinase A (PKA; PRKACA), protein kinase G (PKG; PRKG1), protein kinase C (PKC), and AMP-activated protein kinase (AMPK) ( Figure 1A and 1B). Because the majority of interaction information available to date is not yet domain-specific, interactions in the network cannot so far be resolved at the domain level in general. Therefore, to obtain an EVH1-specific overview of VASP interactions in human platelets, advanced bioinformatical sequence analysis is required. The comprehensive compilation of platelet protein sequences in PlateletWeb now offers the possibility to perform a platelet-wide in silico analysis to identify linear binding motifs targeted by various interaction modules, such as SH3 or EVH1 domains. The detailed list of all EVH1 domain-specific interacting partners of VASP (Figure 1B ) and the complete list of all references are described in further detail in supplementary Table III .
The Combination of In Silico and In Vitro Approaches Identifies Abi-1 as a Novel VASP EVH1 Domain Interactor
The EVH1 domains of VASP, Mena and EVL belong to the class I subgroup of EVH1 domains, which is characterized by a specific consensus sequence FPX⌽P (FP 4 
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Abi-1/VASP Interaction in Human Platelets motif, Xϭany amino acid, ⌽ϭhydrophobic amino acid) in the polyproline-rich sequence of their binding partners. 11 The presence of this conserved sequence pattern permits a protein sequence-based search. On the basis of a curated set of known class I EVH1 target sites 11 we constructed a sequence profile (position-specific scoring matrix) as detailed in the Methods section (supplementary Figure 1 ). Searching the platelet protein database for sequences harboring this motif returned well-established FP 4 motifcontaining binding partners, such as zyxin (ZYX), vinculin (VCL), and FYN-binding protein (FYB), as well as new candidates, such as Rho guanine nucleotide exchange factor (ARH-GEF12) and Abi-1 (ABI1). A list of the top-scoring motifs detected by the in silico search can be found in supplementary Table I . In parallel, an affinity purification with the VASP EVH1 domain was performed to identify interactors in the lysate of "highly purified platelets." 14 Soluble supernatant of platelet lysates was first precleared by GST-labeled Glutathione Sepharose 4B to remove nonspecific GST binding proteins. The precleared cell lysates were incubated with the recombinant GST-EVH1 domain of VASP or GST immobilized on Glutathione Sepharose 4B. Equal amounts of aliquots of GST-EVH1 and GST eluates were separated by SDS-PAGE and stained with Coomassie. Bands that differed between GST-EVH1 and GST eluates were analyzed by mass spectrometry combined with database searches. In total, 32 bands from both eluates (16 each) were analyzed. Proteins identified by mass spectrometric analysis in GST-EVH1 eluates are listed in supplementary Table II. Application of tagged proteins for identifying proteinprotein interaction captures not only direct binding partners but also indirectly or unspecifically bound proteins. To obtain only direct binding partners, we combined the in silico FP 4 motif search and the in vitro results. The intersection contains not only the well-known VASP EVH1 interactors zyxin (ZYX) 16 and Fyn-binding protein (FYB) 18 but also novel potential interactors, such as Abi-1 (ABI1) and WAVE-2 (WASP family protein member 2 [WASF2]) (supplementary Table I ).
Abi-1 has been described before to bind Mena 23 and act together with WAVE-2 to form a complex (WAVE complex) with an important role in the cytoskeletal organization of megakaryocytes and platelets. 24, 25 Because Mena is a close relative of VASP, we selected Abi-1 for further analysis and characterized its interaction with VASP in more detail.
To validate the liquid chromatography tandem mass spectrometry finding of Abi-1 specifically binding to the GST-VASP (1 to 115) fusion protein, eluted protein complexes from affinity chromatography were analyzed by Western blots using a specific antibody against Abi-1. No binding was observed in control experiments, using GST bound to glutathione-Sepharose (Figure 2A ). In addition, control experiments were performed using membrane (␤3) and cytosolic (GAPDH) proteins to show that this assay is specific to VASP and its interaction with Abi-1 ( Figure  2A ). Furthermore, the reciprocal experiment using GST-Abi-1 as bait confirmed the specific binding of VASP by Western blot analysis ( Figure 2B ). Antibody specificity was verified using IgG antibody as control (supplementary materials). Immunoprecipitation with Abi-1 antibodies revealed an endogenous interaction between these 2 proteins in ADP-stimulated platelets ( Figure 2C ).
Characterization of the Newly Defined Abi-1/VASP Interaction
Using another independent method to confirm the interaction of full-length Abi-1 with full-length VASP, Y2H experiments were performed (Figure 3) . To determine the binding region for Abi-1 on VASP, we constructed deletion mutants of VASP. According to its well-known domain organization, 26 we divided VASP into 3 regions, the EVH1 domain (amino acids 1 to 115), the proline-rich region (amino acids 116 to 224), and the EVH2 domain (amino acids 225 to 379) ( Figure  1B) . Various truncated parts of VASP ( Figure 3 ) were tested for their ability to bind Abi-1 in the 2-hybrid system: All constructs containing the EVH1 domain mediated binding to Abi-1. As shown in Figure 3 , yeast coexpressing Abi-1 and EVH1-containing VASP grew on leucine-tryptophan-histidine-adenine-selective plates (third column) and turned blue when tested for the activation of the lacZ gene (fourth column). Furthermore, quantitative lacZ gene activation was performed using an o-nitrophenyl-␤-D-galactopyranosid test (fifth column). However, yeast expressing control bait (vector) and the Abi-1-binding domain or VASP-activation domain showed no growth and no lacZ activation, indicating no self-activation of the proteins in the assay alone (data not shown).
The EVH2 domain, either alone or with the polyprolinerich region, showed no interaction. These results indicate that the interaction between Abi-1 and VASP is mediated by the EVH1 domain.
To test the predicted target site (384 to 395: PPPPPPPPVDYE) in the polyproline-rich region of Abi-1, a mutant Abi-1 (Abi-1⌬383 to 398) lacking these amino acids was constructed. Deletion of the predicted target site in Abi-1 strongly reduced the interaction between full-length VASP and all EVH1 domain-containing fragments (Figure 3) . These observations indicate that the second polyproline-rich stretch of Abi-1 (Abi-1⌬383 to 398) is a target site for the VASP EVH1 domain, as predicted by bioinformatics. This is consistent with and further specifies previously published results indicating an interaction between the EVH1 domain of Mena and an unspecified target site within the polyproline-rich regions of Abi-1. 23 The absence of an interaction between the EVH1 deletion mutant of VASP and full-length Abi-1 (Figure 3 ) further confirmed the finding of Tani et al, 23 who reported that binding of the SRC homology 3 (SH3) domain of Abi-1 to the polyproline-rich region of VASP/Mena is not critical for the interaction. All experiments were repeated using a ␤-galactosidase filter assay yielding the same results as those described for the growth test (Figure 3 shows a representative experiment).
Immune Fluorescence Reveals Activation-Dependent Colocalization of Abi-1 and VASP in Human Platelets
Because Abi-1 and VASP have been reported to regulate filopodial and lamellipodial formation, 7, 27 we next examined the subcellular localization of these 2 proteins in human platelets. Platelets were allowed to attach and spread on fibrinogen-coated coverslips and stained with anti-Abi-1 (green) and anti-VASP (red) antibodies. At the early stages of platelet adhesion to fibrinogen, filopodial formation was observed. VASP was found in both filopodia (white arrow) and lamellipodia (white triangle), whereas Abi-1 showed a clear localization exclusively at lamellipodia (white triangle) ( Figure 4) . A colocalization of VASP and Abi-1 was observed at the lamellipodia (white triangle) in spread platelets (Figure 4 ) and platelets activated with ADP ( Figure 4 ), thrombin (Figure 4 ), arachidonic acid (data not shown), or collagen (data not shown). To investigate Abi-1 and VASP localization during the process of spreading, we fixed platelets at 10, 15, 20, and 45 minutes of incubation after seeding on fibrinogen (Figure 4) . In contrast to the late stages of spreading (Figure 4 ), no colocalization of Abi-1 and VASP could be observed in the early stages (Figure 4 ), suggesting a specific role of this interaction in later stages of spreading.
To determine whether or not Abi-1 is associated with the WAVE complex, we investigated the colocalization of Abi-1 and WAVE-2 ( Figure 4 ). As reported before, WAVE-2 displayed a speckled cytoplasmic staining and rows of dots at the edges of the lamellipodia. 27 The merge of WAVE-2 and Abi-1 staining indicated a partial colocalization of these 2 proteins at the lamellipodia (compare cyan arrow and cyan triangle in Figure 4 ) in human platelets. These observations suggest that Abi-1 may act together with VASP to regulate lamellipodia formation in activated spread platelets.
Discussion
Target prediction based on sequence analysis is possible for interaction domains that recognize specific linear target motifs. Here, we delineate a strategy for the VASP EVH1 domain to extend our recently published platelet interaction network with domain-specific interaction predictions. The VASP EVH1 domain recognizes such a linear motif. This allowed us to conduct a position-specific scoring matrix-based screening of our complete platelet protein database 3 as an example of domain-guided specific platelet protein interactions. Profile-based methods have been used to predict target sites for SH3 domains, 29 and recently advanced approaches have been used to develop classifiers for the prediction of kinase substrates and the site-specific binding of SH2 domains to phosphotyrosines. 30 The motif search successfully confirmed literature-validated EVH1 interactors ( Figure 1A ; supplementary Table III) . Apart from zyxin, vinculin, and Fyn-binding protein, which were included in the profile generating alignment, we also identified a putative EVH1 target site for zonula occludens protein 1 (ZO1; TJP1), which has been isolated as a complex partner of VASP, 31 and our data now suggest a direct interaction between these 2 proteins. Interestingly, a highly scored prediction for diaphanous (DIAPH1) was obtained, which has been described as interacting with VASP in Dictyostelium via its FH2 domain. 31, 32 The predicted target site is located within the FH1 domain, suggesting an EVH1- mediated mechanism for the postulated FH1 facilitated binding of FH2 to VASP.
Inherently, a profile search can only capture targets harboring a previously established binding motif, whereas targets interacting in a different manner will remain elusive. For example, TES, which lacks the FP 4 motif, has recently been described as binding to the EVH1 domain of Mena but not VASP and EVL via its LIM domain. 13 We could identify the LIM domain containing PINCH-1 (LIMS1) in the EVH1 affinity purification of human platelets. Whether this constitutes a direct interaction between PINCH-1 (LIMS1) and the VASP-EVH1 domain remains to be addressed in future studies.
Here we report for the first time an EVH1-mediated interaction between Abi-1 and VASP. This is supported by in silico data and the observation that Abi-1 from highly purified platelets binds to the recombinant EVH1 domain of VASP and vice versa. Y2H analysis confirmed the interaction and showed the EVH1 domain of VASP and the second polyproline-rich region of Abi-1 to be crucial for the interaction. Furthermore, we provide evidence that Abi-1 and VASP are colocalized in spread platelets.
Abi-1 has been described to participate in cytoskeletal reorganization, eg, by mediation of the WAVE-2/Abi-1/ Nap1/Sra-1 complex, which is known to stimulate Arp2/3 and in consequence the actin nucleation activity. 34 Our data suggest Abi-1/WAVE-2/Arp2/3-dependent actin polymerization in human platelets. This is supported by the observation that all known complex partners of Abi-1 can be detected by mass spectrometry (supplementary Table II ), indicating the presence of the entire WAVE-2(WASF2)/Abi-1(ABI1)/ Nap1(NCKAP1)/Sra-1(CYFIP2) complex in platelets. It has been reported that this complex also regulates megakaryocyte differentiation and spreading in platelets. 24, 25 Our results furnish the basis for an additional function of Abi-1, along with VASP, for propagating actin-filament elongation, as well as lamellipodium proliferation and stabilization. Immunofluorescence microscopy shows that during platelet spreading, the localization of Abi-1 and WAVE-2 correlates, but not completely (Figure 4 ). This is in line with bleaching and photoactivation experiments demonstrating that Abi-1 dynamics at the lamellipodium tip do not correlate exactly with the dynamics of the WAVE complex. 3 It is assumed that Abi-1 comprises other actin regulatory complexes in addition to being integrated in the WAVE complex. 36 It is therefore possible that Abi-1 interacts with VASP as well as WAVE-2, but at different phases of spreading. The interaction of Abi-1 and VASP is supported by Lai et al, 35 who demonstrate that half-life times of fluorescence recovery in the tip region of the lamellipodium for Abi-1 and VASP are comparable.
EVH1-containing proteins are targeted to focal adhesions or the leading edge by zyxin, vinculin, 37 or lamellipodin. 38 This suggests a similar targeting of Abi-1 for the localization of VASP. The observations of Eto et al, 24 showing impaired formation of lamellipodial ruffles on fibrinogen in megakaryocytes transduced with Abi-1 short hairpin RNA, indicate a role of Abi-1 for developing lamellipodial structures. The importance of VASP in this process is underscored by the fact that it is recruited to the tips of lamellipodia in amounts that are directly proportional to the rate of protrusion. 39 These data, along with our observations of a direct interaction and colocalization of Abi-1 and VASP at the lamellipodia of spread platelets, point to a concerted role of Abi-1 and VASP during lamellipodia formation.
Our study exemplifies how the integration of experimental and computational interactomics can provide a powerful tool for the identification and functional characterization of protein-protein interactions. With ever-increasing amounts of data on platelet proteome, phosphoproteome, protein structure, and interaction, integrated databases will greatly enhance the biological benefit of these data. In combination with integrative network analysis algorithms 39 and in silico guided experiments, these tools will certainly contribute to a more comprehensive understanding of the complex cellular signaling processes in human platelets. Moreover, these databases and tools provide the basic framework for the integration of functional and clinical data: The characterization of disease-state associated network modules not only can yield new insights into cellular pathophysiology but may also deliver candidates for the development of module-based biomarkers for diagnosis and therapy 39 in the future.
